Analysis of the TCGA database further confirmed that elevated HIG2 mRNA was negatively associated with overall survival (P<0.001, Figure 5C) and disease free survival (P=0.050043, Figure 5D) in GBM patients. The gene discussed is HILPDA; the disease is glioblastoma.